The latest price target for Nuvalent (NASDAQ:NUVL) was reported by BMO Capital on November 13, 2024. The analyst firm set a price target for $134.00 expecting NUVL to rise to within 12 months (a possible 54.24% upside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for Nuvalent (NASDAQ:NUVL) was provided by BMO Capital, and Nuvalent maintained their outperform rating.

The last upgrade for Nuvalent Inc happened on April 1, 2024 when Leerink Partners raised their price target to $110. Leerink Partners previously had a market perform for Nuvalent Inc.

There is no last downgrade for Nuvalent.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nuvalent, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nuvalent was filed on November 13, 2024 so you should expect the next rating to be made available sometime around November 13, 2025.

While ratings are subjective and will change, the latest Nuvalent (NUVL) rating was a maintained with a price target of $132.00 to $134.00. The current price Nuvalent (NUVL) is trading at is $86.88, which is out of the analyst’s predicted range.